MacroGenics | MGNX - Ebitda





Ebitda Изменить Дата
AbbVie USD 5.37B 1.85B 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 12.14B 4.26B 2025-12
Genmab DKK 186M 291M 2025-12
Geron USD -21.29M 11.82M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD 6.3B 2.09B 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 13.43B 744M 2026-06
Xencor USD -51.05M 55.28M 2025-12